Patient-reported pain by clinical outcome in men with metastatic Castration-Resistant Prostate Cancer (mCRPC) receiving Talazoparib (TALA): TALAPRO-1 von Stenzl, A., Saad, F.S., De Bono, J.D.B., Higano, C.H., Barthelemy, P.B., Dorff, T.D., Mehra, N.M., Scagliotti, G.S., Machiels, J.M., Renard, V.R., Maruzzo, M.M., Gurney, H.G., Stirling, A.S., Healy, C.H., Bhattacharyya, H.B., Arondekar, B.A., Niyazov, A.N., Fizazi, K.F.

Volltext